Indicationsa. Type I diabetes
b. Type 2 where maximum doses of OHA have failed(sec.OHA failure)-
c. Type 2 younger patients to prevent tissue damage
d. With complications (specially young pts)
Infections
Ketoacidosis
Neuropathy
Foot lesions
e. pregancy
f. `glucose toxicity